Additional file 4 of Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer
- Siwei Wang (441466)
- Ming Li (91180)
- Jingyuan Zhang (6535169)
- Peng Xing (4742343)
- Min Wu (41570)
- Fancheng Meng (1860748)
- Feng Jiang (95012)
- Jie Wang (16762)
- Hua Bao (544715)
- Jianfeng Huang (570138)
- Binhui Ren (4103542)
- Mingfeng Yu (591016)
- Ninglei Qiu (13894524)
- Houhuai Li (13894527)
- Fangliang Yuan (13894530)
- Zhi Zhang (55283)
- Hui Jia (638620)
- Xinxin Lu (406527)
- Shuai Zhang (115662)
- Xiaojun Wang (50332)
- Youtao Xu (4725339)
- Wenjia Xia (4725342)
- Tongyan Liu (13894533)
- Weizhang Xu (13110417)
- Xinyu Xu (396786)
- Mengting Sun (6931874)
- Xue Wu (317735)
- Yang Shao (511623)
- Qianghu Wang (104424)
- Juncheng Dai (102702)
- Mantang Qiu (434463)
- Jinke Wang (7091)
- Qin Zhang (58638)
- Lin Xu (94491)
- Hongbing Shen (102791)
- Rong Yin (113635)
Publication date
October 2022
DOIAbstract
Additional file 4. Figure S1: Availability of plasma samples. The availability of plasma samples for analysis at each schedule collection time point. Blue and red blocks denote samples collected before and after disease recurrence, respectively. Abbreviations: LUAD – lung adenocarcinoma, LUSC - lung squamous-cell carcinoma, RFS – recurrence-free survival, AT – adjuvant therapy, RT – radiotherapy, LNM – lymph node metastasis
Add to ORKG